Ardelyx, Inc. (LSX:A116X0) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Mott Other companies: Novavax, Inc. (Director · Since at least Jun 16, 2020); Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2024 · Past); Epizyme Inc (Director · May 30, 2013 – Aug 12, 2022 · Past); Omthera Pharmaceuticals Inc (Director · Apr 11, 2013 – Jul 18, 2013 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past); Medimmune Inc (Vice Chair. of the Board, CEO, Director · Feb 23, 2006 – Jun 18, 2007 · Past) | Chairman · Since at least Jun 18, 2014 |
| Annalisa Jenkins Other companies: Skye Bioscience, Inc. (Director · Since at least Feb 29, 2024); Mereo BioPharma Group plc (Director · Since at least Jan 1, 2024); COMPASS Pathways Plc (Director · Since at least Jan 1, 2022); Serina Therapeutics, Inc. (Director · Nov 27, 2018 – Jun 21, 2021 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 6, 2023 · Past); Dimension Therapeutics (President and CEO, Director · Oct 21, 2015 – Nov 7, 2017 · Past) | Director · Apr 20, 2015 – Jun 13, 2019 · Past |
| John Bishop Other companies: Lyra Therapeutics, Inc. (Chief Technology Officer · Feb 27, 2023 – Jan 30, 2024 · Past); Forma Therapeutics Holdings Inc (SVP, Chief Technology Officer · Jun 14, 2021 – Oct 14, 2022 · Past); Veracyte, Inc. (Director · Dec 1, 2014 – Jul 17, 2023 · Past); Cepheid (Chairman of the Board and CEO, Director · Feb 26, 2009 – Nov 4, 2016 · Past); Conceptus Inc (Director · Feb 25, 2009 – Jun 5, 2013 · Past); Momenta Pharmaceuticals Inc (Senior VP, Pharmaceutical Scie · Feb 17, 2006 – May 19, 2016 · Past) | Chief Technical and Quality Officer · Since at least Aug 1, 2025 |
| Richard Rodgers Other companies: Novavax, Inc. (Director · Since at least Oct 29, 2022); Opus Genetics, Inc. (Director · Since at least Dec 2, 2014); Sagimet Biosciences Inc. - Series A (Director · Jul 13, 2023 – Jul 18, 2023 · Past); Tesaro Inc (Executive VP & CFO · Jun 27, 2012 – Mar 6, 2013 · Past); Abraxis BioScience Inc (Senior Vice President and CFO · Jul 9, 2009 – Jul 13, 2009 · Past); Mgi Pharma Inc (Sr. VP and Controller · Jul 15, 2006 – Jan 28, 2008 · Past) | Director · Since at least Jun 18, 2014 |
| Edward R. Conner Other companies: Jade Biosciences, Inc. (Chief Medical Officer · Since Apr 22, 2026); Third Harmonic Bio Inc. (Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Audentes Therapeutics Inc (SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past) | Chief Medical Officer · Since at least Aug 1, 2025 |
| Merdad Parsey Other companies: ArriVent BioPharma, Inc. (Director · Since at least Apr 28, 2025); Sagimet Biosciences Inc. - Series A (Director · Jul 13, 2023 – Jun 5, 2024 · Past); Arcus Biosciences, Inc. (Director · Jul 13, 2020 – Jul 13, 2020 · Past); Gilead Sciences, Inc. (Chief Medical Officer · Nov 1, 2019 – Dec 10, 2024 · Past) | Director · Since at least Apr 28, 2025 |
| Susan Rodriguez Other companies: Monopar Therapeutics Inc. (Chief Commercial and Strategy Officer · Since at least Mar 2, 2026); Avadel Pharmaceuticals PLC (Chief Operating Officer · Since at least May 13, 2025); Veradigm Inc. (Director · Since at least Feb 17, 2023); Heron Therapeutics, Inc. (Director · Sep 20, 2021 – Jan 31, 2025 · Past) | Chief Commercial Officer · May 18, 2020 – May 21, 2024 · Past |
| Gordon Ringold Other companies: Apexigen Inc. (Director · Jul 29, 2022 – Aug 23, 2023 · Past); Alexza Pharmaceuticals Inc (Director · Mar 8, 2006 – Jun 21, 2016 · Past); Maxygen Inc (Director · Jan 3, 2006 – Jun 6, 2012 · Past) | Director · Jun 18, 2014 – Jun 9, 2020 · Past |
| Muna Bhanji Other companies: Intellia Therapeutics, Inc. (Independent Director · Since at least Apr 28, 2022); Veracyte, Inc. (Director · Since at least Mar 19, 2021); Cytokinetics, Incorporated (Director · Since at least Feb 17, 2021) | Director · Since at least Mar 11, 2021 |
| Michael Raab Other companies: Tempest Therapeutics, Inc. (Director · Since at least Jun 25, 2021); Amicus Therapeutics Inc (Director · Since at least Jun 9, 2016) | President & CEO, Director · Since at least Jan 19, 2017 |
| Onaiza Cadoret-Manier Other companies: Ventyx Biosciences Inc (Director · Since at least Jan 11, 2023); Ionis Pharmaceuticals, Inc. (EVP,Chf GL Pdt Str & Oper Ofc · Jan 9, 2020 – Feb 2, 2024 · Past) | Director · Since at least Mar 12, 2020 |
| Robert Bazemore Other companies: Akari Therapeutics PLC (Director · Since at least Sep 17, 2024); Nuvation Bio Inc. (Director · Since at least Sep 3, 2024) | Director · Since at least Jun 14, 2024 |
| Elizabeth Grammer Other companies: Sagimet Biosciences Inc. - Series A (Board Member · Since at least Jul 13, 2023) | See Remarks · Since at least Jun 18, 2014 |
| Justin Renz Other companies: Zevra Therapeutics, Inc. (Chief Financial Officer · Since at least Mar 5, 2026) | Chief Financial Officer · Since at least May 20, 2022 |
| Laura Williams Other companies: Enliven Therapeutics, Inc. (Director · Jun 29, 2021 – Jun 2, 2022 · Past) | Chief Patient Officer Emeritus · Since at least Jun 15, 2022 |
| Michael Kelliher Other companies: Capricor Therapeutics, Inc. (Director · Since at least Jan 5, 2026) | Chief Business Officer · Since at least May 20, 2025 |
| Peter G Schultz Other companies: Symyx Technologies Inc (Director · Jan 3, 2006 – Dec 31, 2006 · Past) | Director · Jun 18, 2014 – Jun 11, 2015 · Past |
| Reginald Seeto Other companies: CareDx, Inc. (See Remarks, Director · Nov 26, 2018 – Oct 2, 2023 · Past) | Chief Operating Officer · Oct 22, 2016 – Jan 16, 2018 · Past |
| William C Bertrand Jr Other companies: Adaptimmune Therapeutics PLC (Chief Operating Officer · Since at least Mar 15, 2017) | Director · Since at least Jun 2, 2016 |
| Caitlin Lowie | Ardelyx Investor Relations and Corporate · Since at least Feb 24, 2026 |
| David P Rosenbaum | Chief Development Officer · Jun 18, 2014 – Nov 20, 2024 · Past |
| Dominique Charmot | Chief Scientific Officer, Director · Jun 18, 2014 – Jun 18, 2014 · Past |
| Eric Duane Foster | Chief Commercial Officer · Since at least May 20, 2025 |
| Felecia Ettenberg | Chief Legal Officer · Since at least Apr 20, 2026 |
| Geoffrey A Block | Director · Jun 15, 2022 – Jun 15, 2023 · Past |
| James Parker Brady | Chief Human Resources Officer · Since at least Jun 18, 2025 |
| Jamie Brady | Chief Human Resources Officer · Since at least Aug 4, 2025 |
| Jeffrey W Jacobs | Chief Scientific Officer · Jun 18, 2014 – Nov 22, 2021 · Past |
| Joseph James Reilly | See Remarks · Since at least Nov 15, 2024 |
| Keith Santorelli | See Remarks · Mar 12, 2020 – Mar 12, 2020 · Past |
| Lindsey Manuel | Associate Director, Corporate Communications · Since at least Nov 3, 2026 |
| Lisa Caperelli | SVP, Investor Relations & Corporate Communications · Since at least Nov 3, 2026 |
| Mike Kelliher | Chief Business Officer · Since at least Aug 4, 2025 |
| Mike Raab | President & Chief Executive Officer · Since at least Aug 25, 2026 |
| Narani Arasaratnam | VP, Corporate Controller · Nov 3, 2014 – Jan 15, 2016 · Past |
| Rajani Dinavahi | Chief Medical Officer · Since at least Apr 1, 2026 |
| Robert Blanks | See Remarks · May 20, 2022 – Nov 20, 2024 · Past |
| Robert Ora Felsch | See Remarks · Mar 10, 2022 – Aug 20, 2024 · Past |
| Sue Hohenleitner | Chief Financial Officer · Since at least Feb 5, 2026 |
| Susan Hohenleitner | Chief Financial Officer · Since at least Nov 4, 2025 |
| William A. Bertrand | Director · Since at least Jun 18, 2026 |